Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pim Aarts

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
The British Journal of Dermatology|October 15, 2025
Metformin in conjunction with doxycycline is not superior to doxycycline monotherapy for hidradenitis suppurativa; results of a phase III double-blinded randomized placebo- controlled trialPim Aarts, Nicole D K Koerts, Johanna C van Huijstee, et al.
Clinical and Experimental Dermatology|July 20, 2024
Needle-free jet injector treatment with bleomycin is efficacious in patients with severe keloids: a randomized, double-blind, placebo-controlled trialVazula Z Bekkers, Katarzyna M Zdunczyk, Liora Bik, et al.
Dermatology (Basel, Switzerland)|October 14, 2021
Prevalence and Clinical Characteristics of Hidradenitis Suppurativa Phenotypes in a Large Dutch CohortKoen Dudink, Pim Aarts, Christine B Ardon, et al.
American Journal of Clinical Dermatology|September 7, 2022
Drug Survival of Oral Retinoids in Hidradenitis Suppurativa: A Real-Life Cohort StudyKlasiena Bouwman, Pim Aarts, Koen Dudink, et al.
Clinical Nutrition ESPEN|March 30, 2020
Identification and prognostic impact of malnutrition in a population screened for liver transplantationRosalie C Oey, Pim Aarts, Nicole S Erler, et al.
Dermatology (Basel, Switzerland)|July 7, 2025
Prevalence of Hidradenitis Suppurativa in the Netherlands: A Cross-Sectional Study as Part of the Global Hidradenitis Suppurativa Atlas (GHiSA)Johanna C van Huijstee, Kelsey R van Straalen, Dorra Bouazzi, et al.
The British Journal of Dermatology|February 22, 2023
Guselkumab for hidradenitis suppurativa: a phase II, open-label, mode-of-action studyKoen Dudink, Klasiena Bouwman, Yanqing Chen, et al.
JAMA Dermatology|September 27, 2023
Outcome Measures for the Evaluation of Treatment Response in Hidradenitis Suppurativa for Clinical Practice: A HiSTORIC Consensus StatementNicole Mastacouris, Rachel Tannenbaum, Andrew Strunk, et al.
JAMA Dermatology|November 26, 2025
Standardization of Lesion Classification and Assessment by Investigators in Clinical Trials for Hidradenitis Suppurativa: A Consensus Exercise Using a Modified Delphi ApproachAmit Garg, Andrew Strunk, Bria Midgette, et al.
The British Journal of Dermatology|March 5, 2026
Evaluating the diagnostic accuracy of a screening questionnaire for detecting hidradenitis suppurativa: a pooled analysis of accuracy measures from the Global Hidradenitis Suppurativa Atlas (GHiSA) studyDorra Bouazzi, Søren Lophaven, Paa Gyasi Hagan, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
The British Journal of Dermatology|October 15, 2025
Metformin in conjunction with doxycycline is not superior to doxycycline monotherapy for hidradenitis suppurativa; results of a phase III double-blinded randomized placebo- controlled trialPim Aarts, Nicole D K Koerts, Johanna C van Huijstee, et al.
Clinical and Experimental Dermatology|July 20, 2024
Needle-free jet injector treatment with bleomycin is efficacious in patients with severe keloids: a randomized, double-blind, placebo-controlled trialVazula Z Bekkers, Katarzyna M Zdunczyk, Liora Bik, et al.
Dermatology (Basel, Switzerland)|October 14, 2021
Prevalence and Clinical Characteristics of Hidradenitis Suppurativa Phenotypes in a Large Dutch CohortKoen Dudink, Pim Aarts, Christine B Ardon, et al.
American Journal of Clinical Dermatology|September 7, 2022
Drug Survival of Oral Retinoids in Hidradenitis Suppurativa: A Real-Life Cohort StudyKlasiena Bouwman, Pim Aarts, Koen Dudink, et al.
Clinical Nutrition ESPEN|March 30, 2020
Identification and prognostic impact of malnutrition in a population screened for liver transplantationRosalie C Oey, Pim Aarts, Nicole S Erler, et al.
Dermatology (Basel, Switzerland)|July 7, 2025
Prevalence of Hidradenitis Suppurativa in the Netherlands: A Cross-Sectional Study as Part of the Global Hidradenitis Suppurativa Atlas (GHiSA)Johanna C van Huijstee, Kelsey R van Straalen, Dorra Bouazzi, et al.
The British Journal of Dermatology|February 22, 2023
Guselkumab for hidradenitis suppurativa: a phase II, open-label, mode-of-action studyKoen Dudink, Klasiena Bouwman, Yanqing Chen, et al.
JAMA Dermatology|September 27, 2023
Outcome Measures for the Evaluation of Treatment Response in Hidradenitis Suppurativa for Clinical Practice: A HiSTORIC Consensus StatementNicole Mastacouris, Rachel Tannenbaum, Andrew Strunk, et al.
JAMA Dermatology|November 26, 2025
Standardization of Lesion Classification and Assessment by Investigators in Clinical Trials for Hidradenitis Suppurativa: A Consensus Exercise Using a Modified Delphi ApproachAmit Garg, Andrew Strunk, Bria Midgette, et al.
The British Journal of Dermatology|March 5, 2026
Evaluating the diagnostic accuracy of a screening questionnaire for detecting hidradenitis suppurativa: a pooled analysis of accuracy measures from the Global Hidradenitis Suppurativa Atlas (GHiSA) studyDorra Bouazzi, Søren Lophaven, Paa Gyasi Hagan, et al.
Pageof 3